One of the postoperative infections that are cause for concerns is known as MRSA, as methicillin-resistant Staphylococcus aureus. Many infections that begin after surgery can be directly attributed to MRSA and it should be seen as the main leading contagion that other surgical hair operation diseases eventually become. The treatment for MRSA is recommended as a deep cleaning of the patch of hair that is affected. In order to initiate empiric therapy, a twice daily course of trimethoprim 160mg sulfamethoxazole is suggested. There has also been some success in the use of rifampin (300 mg to be taken daily). The response rate of the MRSA infection is notably slower in this regard.
With the impending sensitivity and culture results, the treatment can be modified to suit the individual patient’s needs. If there is a treatment of MRSA that fails the first course of antibiotics, then a medicinal application of Linezolid is a suggested course of action. With all infectious diseases though, it is best to approach the situation from a sensible, yet cautious direction.
Many of the hair loss surgeries do not consider MRSA to be a massive issue, or a problem that plagues them after each surgery. The rate seems to be at one in every 2000 surgeries – or even less than this reported number. Surgeons should note that if a cluster of cases suddenly occurs, then there may be an internal issue with their operating procedures.
As a professional hair restoration surgeon, it is your doctor’s duty to assist you in regards to this rare outbreak of surgical hair disease.